Human Amyloid Imaging (HAI) Meeting

摘要： 该提案请求支持由Keith A. 医学博士约翰逊、医学博士威廉·J·贾格斯特、医学博士威廉·E·克伦克和医学博士切斯特·马西斯 2018年1月17日至19日，佛罗里达州迈阿密。会议将以独特的简报组合为特色 研究报告、口头陈述、主题演讲、开放讨论、简明授课方法 讲座、海报会议和网络广播。这些演讲将经过同行评审，并将重点放在 关于阿尔茨海默病生物学和生物标记物研究中的核心争议。其目的是为了 延续前11次HAI会议的传统，汇聚了一批跨学科的近距离 给400名小组成员和演讲者，他们将从神经病理学，神经化学， 心理学、神经学、分子成像、临床试验和生物标记物研究。会议将于 为致力于讨论切割的学术和行业科学家提供一个高度互动的平台 人类成像中与阿尔茨海默氏症相关的淀粉样β蛋白和/或其他生物标志物的边缘研究 相关疾病。我们还将继续保持只展示最新、最重要的作品的传统 外地在不到两个月前再次对提交的材料进行同行审查 开会。

ABSTRACT: This proposal requests support for the 12th Human Amyloid Imaging conference organized by Keith A. Johnson, MD, William J. Jagust, MD, William E. Klunk, MD, PhD, and Chester Mathis, MD, to be held in Miami, Florida, January 17-19, 2018. The meeting will feature a unique combination of brief research reports, oral presentations, keynote lectures, open discussion, brief didactic methods lectures, a poster session, and a webcast. These presentations will be peer-reviewed and will focus on the core controversies in Alzheimer's disease biology and biomarker research. The aim is to continue the tradition of the first 11 HAI meetings, bringing together a cross-disciplinary mass of close to 400 panelists and presenters who will provide perspectives from neuropathology, neurochemistry, psychology, neurology, molecular imaging, clinical trials and biomarker research. The meeting will serve as a highly interactive platform for academic and industry scientists intent on discussing cutting edge research in human imaging of amyloid-beta and/or other biomarkers that pertain to Alzheimer's related disease. We will also continue the tradition of featuring only the most recent, important work in the field by again conducting peer–review of submitted material less than two months prior to the meeting.